Meyka Pro banner
Biosino Bio-Technology & Science Inc.

Biosino Bio-Technology & Science Inc. (8247.HK) Stock Overview

Explore Biosino Bio-Technology & Science Inc.’s financial performance, market position, analyst ratings, and future outlook.

8247.HKHKSE
HealthcareMedical - Diagnostics & Research
HK$3.12
HK$0.04(1.30%)
Hong Kong Market opens in 0h 38m

Biosino Bio-Technology & Science Inc. (8247.HK)

Meyka AI Score

Z

Key Financials

Market Cap200.6M
P/E RatioN/A
EPS (TTM)$-0.41
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$6.17
3 Months$2.29
1 Year Target$0.00

8247.HK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Biosino Bio-Technology & Science Inc. (8247.HK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 200.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.30%
5-Day Change
23.32%
1-Month Change
8.71%
3-Month Change
-10.34%
6-Month Change
-49.60%
Year-to-Date (YTD) Change
38.05%
1-Year Change
300.00%
3-Year Change
231.91%
5-Year Change
101.29%
All-Time (Max) Change
15.56%

Contact Information

NaN
No. 27, Chaoqian Road, Beijing, BJ, 102200

Company Facts

4,500 Employees
IPO DateFeb 27, 2006
CountryCN
Actively Trading

Frequently Asked Questions